The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
Open accessAbstract
Parkinson disease (PD) is the second most common neurodegenerative movement disorder. Pharmacological animal models are invaluable tools to study the pathological mechanisms of PD. Currently, invertebrate and vertebrate animal models have been developed by using several main neurotoxins, such as 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, paraquat, and rotenone. These models achieve to some extent to reproduce the key features of PD, including motor defects, progressive loss of dopaminergic neurons in substantia nigra pars compacta, and the formation of Lewy bodies. In this review, we will highlight the pathogenic mechanisms of those neurotoxins and summarize different neurotoxic animal models with the hope to help researchers choose among them accurately and to promote the development of modeling PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
Chiba, K., Trevor, A., & Castagnoli, N. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91293-2 · Cited by 1,097
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Structural Properties of the Caenorhabditis elegans Neuronal Network
Varshney, L. R., Chen, B. L., Paniagua, E., Hall, D. H., & Chklovskii, D. B. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001066 · Cited by 867 · cited 2×
“elegans is a 959-cell nematomorph with a simple nervous system which is composed of 302 neurons and a dopaminergic circuitry of exactly eight neurons, providing a framework for studying the mammalian brain (Varshney et al., 2011).”
BackgroundRole of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease
Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718 · cited 1×
“MPPþ selectively damages dopaminergic neurons due to its inhibiting effect on complex I, resulting in both reduction of ATP synthesis and accumulation of reactive oxygen species (ROS; Figure 2; Burns et al., 1985; Yan et al., 2013).”
BackgroundHuman iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
Kikuchi, T., Morizane, A., Doi, D., Magotani, H., Onoe, H., Hayashi, T., Mizuma, H., Takara, S., Takahashi, R., Inoue, H., et al. (2017) · Nature · doi:10.1038/nature23664 · Cited by 702
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
The parkinson's complex: Parkinsonism is just the tip of the iceberg
Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 583
Rink, E., & Wullimann, M. F. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03174-7 · Cited by 472
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
Thomas, K. J., McCoy, M. K., Blackinton, J., Beilina, A., van der Brug, M., Sandebring, A., Miller, D., Maric, D., Cedazo-Minguez, A., & Cookson, M. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq430 · Cited by 454
Karpinar, D. P., Balija, M. B. G., Kügler, S., Opazo, F., Rezaei‐Ghaleh, N., Wender, N., Kim, H., Taschenberger, G., Falkenburger, B. H., Heise, H., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.257 · Cited by 432
Animal models of Parkinson’s disease
Blandini, F., & Armentero, M. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08491.x · Cited by 418
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans
Nass, R., Hall, D. H., Miller, D. M., & Blakely, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042497999 · Cited by 417
Meulener, M., Whitworth, A. J., Armstrong-Gold, C. E., Rizzu, P., Heutink, P., Wes, P. D., Pallanck, L. J., & Bonini, N. M. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.064 · Cited by 353
Diao, J., Burré, J., Vivona, S., Cipriano, D. J., Sharma, M., Kyoung, M., Südhof, T. C., & Brunger, A. T. (2013) · eLife · doi:10.7554/elife.00592 · Cited by 350
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331
The 6-hydroxydopamine model: News from the past
Blandini, F., Armentero, M.-T., & Martignoni, E. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.015 · Cited by 311
Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease
Bretaud, S., Lee, S., & Guo, S. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.06.014 · Cited by 305
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine
Glinka, Y. Y., & Youdim, M. B. H. (1995) · European Journal of Pharmacology: Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)90040-3 · Cited by 283
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263
Burns, R. S., LeWitt, P. A., Ebert, M. H., Pakkenberg, H., & Kopin, I. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505303122203 · Cited by 244
The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential
Chaudhuri, K. R., Yates, L., & Martinez-Martin, P. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0072-6 · Cited by 243
Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction
Park, J., Kim, S. Y., Cha, G.-H., Lee, S. B., Kim, S., & Chung, J. (2005) · Gene · doi:10.1016/j.gene.2005.06.040 · Cited by 213
Drui, G., Carnicella, S., Carcenac, C., Favier, M., Bertrand, A., Boulet, S., & Savasta, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.3 · Cited by 210
Ramsay, R. R., Krueger, M. J., Youngster, S. K., Gluck, M. R., Casida, J. E., & Singer, T. P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11409.x · Cited by 209
DABBENI-SALA, F., DI Santo, S., FRANCESCHINI, D., D. SKAPER, S., & PIETRO GIUSTI, A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0129com · Cited by 192
Zhang, C., Li, C., Chen, S., Li, Z., Jia, X., Wang, K., Bao, J., Liang, Y., Wang, X., Chen, M., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2016.10.019 · Cited by 190
Cannon, J. R., & Greenamyre, J. T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.025 · Cited by 189
Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine
Glinka, Y., Tipton, K. F., & Youdim, M. B. H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66052004.x · Cited by 176
Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease
Xu, Q., Langley, M. R., Kanthasamy, A. G., & Reddy, M. B. (2017) · Journal of Nutrition · doi:10.3945/jn.117.255034 · Cited by 164
A tale on animal models of Parkinson's disease
Bezard, E., & Przedborski, S. (2011) · Movement Disorders · doi:10.1002/mds.23696 · Cited by 159
Increased striatal dopamine turnover following acute administration of rotenone to mice
Thiffault, C., Langston, J. W., & Monte, D. A. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02960-7 · Cited by 149
Niso‐Santano, M., González‐Polo, R. A., Pedro, J. M. B., Gómez‐Sánchez, R., Lastres‐Becker, I., Ortiz‐Ortiz, M. A., Soler, G., Morán, J. M., Cuadrado, A., & Fuentes, J. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.024 · Cited by 145
α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
Purisai, M. G., McCormack, A. L., Langston, J. W., Johnston, L. C., & Monte, D. A. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.028 · Cited by 142
Ungerstedt, U., Ljungberg, T., & Steg, G. (1974) · PubMed · Cited by 138
Gibrat, C., Saint‐Pierre, M., Bousquet, M., Lévesque, D., Rouillard, C., & Cicchetti, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06072.x · Cited by 136
Effects of l ‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration
McCormack, A. L., & Monte, D. A. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 131
Paraquat Neurotoxicity Is Mediated by a Bak-dependent Mechanism
Fei, Q., McCormack, A. L., Monte, D. A. D., & Ethell, D. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708451200 · Cited by 124
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124 · cited 1×
“Once in the dopaminergic neurons, rotenone inhibits the activity of mitochondrial complex I, causing the production of ROS and mitochondrial dysfunction (Figure 2; Cannon and Greenamyre, 2013; Terron et al., 2018).”
BackgroundFeng, C., Wen, Z., Huang, S., Hung, H.-C., Chen, C., Yang, S., Chen, N., Wang, H., Hsiao, C., & Chen, W.-F. (2014) · Zebrafish · doi:10.1089/zeb.2013.0950 · Cited by 112
Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease
Shimoji, M., Zhang, L., Mandir, A. S., Dawson, V. L., & Dawson, T. M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.01.012 · Cited by 111
No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
Halliday, G. M., Herrero, M. T., Murphy, K., McCann, H., Ros‐Bernal, F., Barcia, C., Mori, H., Blesa, F. J., & Obeso, J. A. (2009) · Movement Disorders · doi:10.1002/mds.22481 · Cited by 108
Smeyne, R. J., Breckenridge, C. B., Beck, M. J., Jiao, Y., Butt, M. T., Wolf, J. C., Zadory, D., Minnema, D. J., Sturgess, N. C., Travis, K. Z., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164094 · Cited by 105
Hernández-Baltazar, D., Mendoza‐Garrido, M. E., & Martínez‐Fong, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070951 · Cited by 104
Srivastava, R., Brouillet, E., Beal, M. F., Storey, E., & Hyman, B. T. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90114-q · Cited by 103
The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease
Zeng, X., Jia, J., Kwon, Y.-W., Wang, S., & Bai, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.013 · Cited by 101
Self-citationJiang, P., Gan, M., Ebrahim, A. S., Castanedes‐Casey, M., Dickson, D. W., & Yen, S.-H. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.001 · Cited by 101
Kumar, A., Sharma, N., Gupta, A. K., Kalonia, H., & Mishra, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.050 · Cited by 100
1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine induced Parkinson's disease in zebrafish
Nukala, S. B., Murthy, C. L. N., Kakara, S., Sharma, R., Swamy, C. V. B., & Idris, M. M. (2016) · PROTEOMICS · doi:10.1002/pmic.201500291 · Cited by 100
Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease
Biosa, A., Sandrelli, F., Beltramini, M., Greggio, E., Bubacco, L., & Bisaglia, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.005 · Cited by 99
Chen, Y., Zhang, D.-Q., Liao, Z., Wang, B., Gong, S., Wang, C., Zhang, M.-Z., Wang, G., Cai, H., Liao, F., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/1750-1326-10-4 · Cited by 95
Chiu, C., Yeh, T., Lai, S., Chou, Y. W., Chen, C., Mochly‐Rosen, D., Huang, Y.-C., Chen, Y.-J., Chen, C.-L., Chang, Y.-M., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.016 · Cited by 93
Masilamoni, G. J., & Smith, Y. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1774-z · Cited by 92
McCormack, A. L., Mak, S. K., Shenasa, M., Langston, J. W., Forno, L. S., & Monte, D. A. D. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318180f0bd · Cited by 89
Modelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
Alvarez‐Fischer, D., Guerreiro, S., Hunot, S., Saurini, F., Marien, M. R., Sokoloff, P., Hirsch, É. C., Hartmann, A., & Michel, P. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05651.x · Cited by 87
Ma, Y., Zhan, M., OuYang, L., Li, Y., Chen, S. X., Wu, J., Chen, J., Luo, C., & Lei, W. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.039 · Cited by 85
Exposure to Mitochondrial Genotoxins and Dopaminergic Neurodegeneration in Caenorhabditis elegans
González-Hunt, C. P., Leung, M. C. K., Bodhicharla, R. K., McKeever, M. G., Arrant, A. E., Margillo, K. M., Ryde, I. T., Cyr, D. D., Kosmaczewski, S. G., Hammarlund, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114459 · Cited by 85
Peng, J., Stevenson, F. F., Oo, M. L., & Andersen, J. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.045 · Cited by 84
Modulation of Fictive Feeding by Dopamine and Serotonin inAplysia
Kabotyanski, E. A., Baxter, D. A., Cushman, S. J., & Byrne, J. H. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.1.374 · Cited by 78
Hegazy, M. A., Maklad, H. M., Samy, D. M., Abdelmonsif, D. A., Sabaa, B. M. E., & Elnozahy, F. Y. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.011 · Cited by 78
Chong, C., Zhou, Z.-Y., Razmovski‐Naumovski, V., Cui, G., Zhang, L.-Q., Sa, F., Hoi, M. P. M., Chan, K., & Lee, S. M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.069 · Cited by 77
Galpern, W. R., Frim, D. M., Tatter, S. B., Altar, C. A., Beal, M. F., & Isacson, O. (1996) · Cell Transplantation · doi:10.1016/0963-6897(95)02030-6 · Cited by 75
Ravenstijn, P. G. M., Merlini, M., Hameetman, M., Murray, T. K., Ward, M., Lewis, H., Ball, G., Mottart, C., de Goyet, C. D. V., Lemarchand, T., et al. (2007) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2007.10.003 · Cited by 75
Fornai, F., Lenzi, P., Ferrucci, M., Lazzeri, G., di Poggio, A. B., Natale, G., Busceti, C. L., Biagioni, F., Giusiani, M., Ruggieri, S. A., et al. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.02.022 · Cited by 75
C. elegans as a model system to accelerate discovery for Parkinson disease
Martinez, B., Caldwell, K. A., & Caldwell, G. A. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.011 · Cited by 74
Maász, G., Zrínyi, Z., Reglődi, D., Petrovics, D., Rivnyak, A., Kiss, T., Jüngling, A., Tamás, A., & Pirger, Z. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.027185 · Cited by 69
Muthukumaran, K., Leahy, S., Harrison, K., Sikorska, M., Sandhu, J. K., Cohen, J. S., Keshan, C., Lopatin, D., Miller, H., Borowy‐Borowski, H., et al. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-21 · Cited by 68
Hu, X., Song, Q., Li, X., Li, D., Zhang, Q., Meng, W., & Zhao, Q. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.022 · Cited by 68
Xu, Y., Cui, C., Sun, M., Zhu, Y., Chu, M., Shi, Y., Lin, S. L., Yang, X., & Shen, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26010 · Cited by 68
Jahromi, S. R., Haddadi, M., Shivanandappa, T., & Ramesh, S. R. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.048 · Cited by 64
Rescue of Pink1 Deficiency by Stress-Dependent Activation of Autophagy
Zhang, Y., Nguyen, D. T., Olzomer, E. M., Poon, G. P., Cole, N. J., Puvanendran, A., Phillips, B. R., & Hesselson, D. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.03.005 · Cited by 64
Worth, A. J., Basu, S. S., Snyder, N. W., Mesaros, C., & Blair, I. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591354 · Cited by 63
Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson’s Disease
Powers, R., Lei, S., Anandhan, A., Marshall, D. D., Worley, B., Cerny, R. L., Dodds, E. D., Huang, Y., Panayiotidis, M. I., Pappa, A., et al. (2017) · Metabolites · doi:10.3390/metabo7020022 · Cited by 61
Naudet, N., Antier, E., Gaillard, D., Morignat, E., Lakhdar, L., Baron, T., & Bencsik, A. A. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx092 · Cited by 59
Feng, C., Hung, H.-C., Huang, S., Chen, C., Chen, Y., Chen, C.-Y., Yang, S., Wang, H.-M. D., Sung, P., Sheu, J., et al. (2016) · Marine Drugs · doi:10.3390/md14100187 · Cited by 57
Hosamani, R., Krishna, G., & ., M. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000149 · Cited by 54
Avagliano, C., Russo, R., Caro, C. D., Cristiano, C., Rana, G. L., Piegari, G., Paciello, O., Citraro, R., Russo, E., Sarro, G. D., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.004 · Cited by 54
A mutation in Drosophila methuselah resists paraquat induced Parkinson-like phenotypes
Shukla, A. K., Pragya, P., Chaouhan, H. S., Patel, D. K., Abdin, M. Z., & Chowdhuri, D. K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.008 · Cited by 52
Varga, S. J., Cheng, Q., Podolsky, E., & Lee, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.021 · Cited by 51
Ren, J.-P., Zhao, Y., & Sun, X. (2009) · PubMed · Cited by 49
Alam, G., Edler, M. K., Burchfield, S. L., & Richardson, J. R. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.008 · Cited by 48
Prajapati, S. K., Garabadu, D., & Krishnamurthy, S. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9693-6 · Cited by 45
Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse
Becker, B., Demirbas, M., Johann, S., Zendedel, A., Beyer, C., Clusmann, H., Haas, S. J.-P., Wree, A., Tan, S. K. H., & Kipp, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0637-9 · Cited by 45
Kumar, A., Christian, P. K., Panchal, K., Guruprasad, B. R., & Tiwari, A. K. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2016.1275917 · Cited by 44
NMR Metabolomics Analysis of Parkinson's Disease
Lei, S., & Powers, R. (2013) · Current Metabolomics · doi:10.2174/2213235x113019990004 · Cited by 39
Matteo, V. D., Benigno, A., Pierucci, M., Giuliano, D. A., Crescimanno, G., Esposito, E., & Giovanni, G. D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.015 · Cited by 38
Stednitz, S. J., Freshner, B. C., Shelton, S. M., Shen, T., Black, D., & Gahtan, E. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.11.001 · Cited by 38
Giacoppo, S., Bramanti, P., & Mazzon, E. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000871 · Cited by 38
Wu, K.-C., Lu, Y.-H., Peng, Y., Tsai, T., Kao, Y.-H., Yang, H.-T., & Lin, C. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.162 · Cited by 37
Lehtonen, Š., Jaronen, M., Vehviläinen, P., Lakso, M., Rudgalvyte, M., Keksa-Goldsteine, V., Wong, G., Courtney, M. J., Koıstınaho, J., & Goldsteins, G. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6402 · Cited by 35
Li, Y., Peng, S.-X., Xu, Y., Lin, S. L., Li, Y., Liu, C., Zhao, H., Wang, L., & Shen, Y. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25749 · Cited by 35
Zhou, S., Wang, Z., & Klaunig, J. E. (2013) · Europe PMC (PubMed Central) · Cited by 32
Offenburger, S.-L., Jongsma, E., & Gartner, A. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007106 · Cited by 28
Hwang, C. J., Lee, H. P., Choi, D., Jeong, H. S., Kim, T. H., Lee, T. H., Kim, Y. M., Moon, D. B., Park, S.-S., Kim, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10504 · Cited by 26
Ferrigno, A., Vairetti, M., Ambrosi, G., Rizzo, V., Richelmi, P., Blandini, F., & Armentero, M. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12410 · Cited by 23
Basil, A. H., Sim, J. P. L., Lim, G. G. Y., Lin, S., Chan, H.-Y., Engelender, S., & Lim, K. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00241 · Cited by 21
Kachroo, A., & Schwarzschild, M. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.031 · Cited by 18
Shi, L., Huang, C., Luo, Q., Xia, Y., Liu, H., Li, L., Liu, W., Ma, W., Fang, J. S., Tang, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22348 · Cited by 16
Liao, J., Morin, L. W., & Ahmad, S. T. (2014) · Journal of Visualized Experiments · doi:10.3791/51625 · Cited by 10
Cited by
Historical Perspective: Models of Parkinson’s Disease
Chia, S. J., Tan, E.-K., & Chao, Y.-X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072464 · Cited by 401
The role of histone modifications: from neurodevelopment to neurodiseases
Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 297
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Zhao, Y., Zhang, Z., Qin, S., Fan, W., Li, W., Liu, J., Wang, S., Xu, Z., & Zhao, M. (2021) · Neural Plasticity · doi:10.1155/2021/9926445 · Cited by 68
Jiang, Z., Wang, X., Zhang, H., Yin, J., Zhao, P., Yin, Q., & Wang, Z. (2023) · MedComm · doi:10.1002/mco2.268 · Cited by 50
Metadata
- Authors
- Zeng, X.-S., Geng, W.-S., & Jia, J.-J.
- Venue
- ASN Neuro
- Publisher
- Informa UK Limited
- Published
- 2018-01
- Volume
- 10
- Issue
- 1
- Pages
- 1759091418777438-1759091418777438
- ISSN
- 1759-0914 (ISSN-L)
- OpenAlex
- W2805999712
- Cited by
- 275
- References
- 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.